---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-001271"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-01-12T23:59:59+00:00"
generated_at: "2026-06-20T15:56:57.279109+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience receives Nasdaq deficiency notice for minimum bid price non-compliance

## Summary
- On Jan 11, 2023, INVO received Nasdaq notice of non-compliance with minimum bid price of $1.00 per share.
- Company has 180 days, until July 10, 2023, to regain compliance by closing at $1.00 for 10 consecutive business days.
- If non-compliant after first period, Nasdaq may grant a second 180-day period if other listing standards are met.
- Failure to cure could lead to delisting; company may appeal Nasdaq's determination.

## SEC filing metadata
- accession: 0001493152-23-001271
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-01-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223001271/0001493152-23-001271-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223001271/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-001271
- JSON: https://secwatch.observer/filing/0001493152-23-001271.json
- Plain text: https://secwatch.observer/filing/0001493152-23-001271.txt

## Key facts
- Listing & Compliance Notices
  INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: January 11, 2023, INVO Bioscience Inc. (the “Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) listing qualifications group indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing under Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing of the Company’s common stock, and its common stock will continue to trade on T
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223001271/0001493152-23-001271-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.